Long‐term outcomes of 6‐mm diameter fully covered self‐expandable metal stents in benign refractory pancreatic ductal stricture

Oh, Dongwook; Lee, Jae Hoon; Song, Tae Jun; Park, Do Hyun; Lee, Sung Koo; Kim, Myung–Hwan; Lee, Sang Soo

doi:10.1111/den.13041

Cited by 41 publications

(52 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, recently, there have been several reports regarding the good results in longterm follow-up of the placement of FCSEMS. Oh et al 62 reported that stents could easily be removed at a median of 7.5 months after their insertion in all cases without migration during placement, and 13 (86.7%) of the 15 patients who had responded to pancreatic stenting maintained the response during follow-up (median of 47.3 months) after definite stent removal. Tringali et al 63 showed that FCSEMS removability from the painful pancreatic duct was feasible in all cases, and 90% of the patients were asymptomatic after 3 years.…”

Section: Endoscopic Therapy For Benign Pancreatic Ductal Stricturementioning

confidence: 99%

Recent innovations in therapeutic endoscopy for pancreatobiliary diseases

Irisawa¹,

Miyoshi

Itoi

et al. 2019

Digestive Endoscopy

View full text Add to dashboard Cite

The development of endoscopic treatment for pancreatobiliary diseases in recent years is remarkable. In addition to conventional transpapillary treatments under endoscopic retrograde cholangiopancreatography (ERCP), new endoscopic ultrasound‐guided therapy is being developed and implemented. On the other hand, due to the development/improvement of various devices such as new metal stents, a new therapeutic strategy under ERCP is also advocated. The present review focuses on recent advances in the endoscopic treatment of pancreatic pseudocysts, walled‐off necrosis, malignant biliary strictures, and benign biliary/pancreatic duct strictures.

show abstract

Section: Endoscopic Therapy For Benign Pancreatic Ductal Stricturementioning

confidence: 99%

Recent innovations in therapeutic endoscopy for pancreatobiliary diseases

Irisawa¹,

Miyoshi

Itoi

et al. 2019

Digestive Endoscopy

View full text Add to dashboard Cite

show abstract

“…SEMS insertion in to a pancreatic duct stricture has also been shown to improve pain in 15/18 of patients after a follow-up of 47 months with no stent migration 72. Stones in the main pancreatic duct can be removed with ERCP but if ≥5 mm they are likely to require extracorporeal shock wave lithotripsy.…”

Section: Management Of Cpmentioning

confidence: 99%

Practical guide to the management of chronic pancreatitis

Jalal

Campbell

Hopper

2018

Frontline Gastroenterol

View full text Add to dashboard Cite

Chronic pancreatitis (CP) is an irreversible fibroinflammatory disorder of the pancreas. It presents with relapsing, remitting upper abdominal pain accompanied by features of malabsorption due to pancreatic exocrine insufficiency and endocrine deficiency with the development of diabetes mellitus. The associated increased hospitalisation and high economic burden are related to CP often presenting at advanced stage with irreversible consequences. Diagnosing CP at an early stage is still challenging and therefore CP is believed to be under-reported. Our understanding of this disease has evolved over the last few years with attempts to redesign the definition of CP. Better recognition of the risk factors and conditions associated with CP can lead to an earlier diagnosis and coupled with a multidisciplinary approach to treatment, ultimately reduce complications. This article reviews the epidemiology, risk factors, diagnosis and management of CP.

show abstract

“…4 Within this context, several groups have evaluated the use of fully covered selfexpanding metal stents as a salvage maneuver for these strictures. [5][6][7] Although currently available metal stents are designed for biliary indications, limited case series have found high success rates for pancreatic strictures but with the important caveat that randomized studies have not been performed for refractory pancreatic duct strictures.…”

mentioning

confidence: 99%